- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2009
- Public Summary Document (PSD) March 2009 PBAC Meeting - PDF
Methylnaltrexone bromide – March 2009
Methylnaltrexone bromide, injection, 12 mg in 0.6 mL (base), Relistor®, March 2009
Last updated
17 July 2009